Geneva, Switzerland, May 26, 2021 – Abologix has been named one of the winners of the Venture Kick stage III start up competition. This award is the pinnacle of the Venture Kick competition. The company will receive 150 000 CHF from Venture Kick in the form of a convertible loan.
top of page
Geneva, Switzerland, December 23, 2024 – Abologix has been awarded 100,000 CHF by the KICK FUND to progress its advanced preclinical...
Geneva, Switzerland, November 23, 2023 – Abologix successfully completes the Innosuisse-funded program for the initial characterization...
Geneva, Switzerland, December 20, 2022 – Abologix nominates monoclonal antibody H225 (blocker of JAM-C, Junction Adhesion Molecule C) as...
bottom of page
Comments